Myeloma University: Selinexor and Venetoclax
Two drugs used to treat relapsed multiple myeloma
Description:
Review the newer drugs used to treat multiple myeloma in a relapse setting: selinexor and venetoclax.
Module Objectives:
- Learn about the uses of selinexor and venetoclax in the context of relapsed myeloma
- Educate healthcare professionals about the potential side effects and considerations of selinexor and venetoclax
Instructor:
Beth Faiman, PhD, RN, MSN, APRN-BC, AOCN®, FAAN
Featured
Visit Myeloma University
Created by the International Myeloma Foundation's Nurse Leadership Board, Myeloma University is an educational series for nurses and other healthcare professionals to gain knowledge about multiple myeloma.
Disclaimer:
The information contained in this website does not constitute medical advice, diagnosis or treatment and is for informational purposes only. The information in this website is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition. If you think you may have a medical emergency, call your doctor or 911 immediately.
With support from:
Bristol Myers Squibb, GSK, and Sanofi
